Immunoblot and ChIP-PCR showed that silencing of KRT19 led to an increased p53 level in NSCLC cells and significantly enhanced p53 binding to the CDKN1A promoter in PC-9 cells compared to controls (Fig. 5D-E). Here, KRT19 is linked to non-small cell lung carcinoma.